Short Interest in Mesoblast Limited (OTCMKTS:MEOBF) Rises By 25.1%

Mesoblast Limited (OTCMKTS:MEOBF) was the recipient of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 13,699,800 shares, an increase of 25.1% from the November 15th total of 10,952,000 shares. Based on an average daily trading volume, of 65,200 shares, the short-interest ratio is presently 210.1 days.

Mesoblast Price Performance

Shares of OTCMKTS MEOBF remained flat at $1.03 during mid-day trading on Monday. The stock had a trading volume of 4,156,982 shares, compared to its average volume of 74,003. Mesoblast has a 52 week low of $0.10 and a 52 week high of $1.41. The firm’s fifty day moving average is $1.06 and its two-hundred day moving average is $0.84.

Mesoblast Company Profile

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.